Tetrahydrocannabivarin

N/A

Report date: 2022/10/18 20:00:54
NME

Base Information

Drug NameTetrahydrocannabivarin
Drug Alias NameTetrahydrocannabivarolTetrahydrocannabivarin-9Delta-9-tetrahydrocannabivarinGWP-42004GW-42004 +[8] 
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionCannabinoid CB1 receptor antagonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsObesity, MorbidHypercholesterolemiaDyslipidemias +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesRomaniaUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGw Pharmaceuticals Plc
China Registration ClassN/A

Develop Information

Active CompaniesMedical Life Care Planners LLC
Inactive CompaniesJazz Pharmaceuticals Plc
Active IndicationsObesity, MorbidHypercholesterolemiaMetabolic Syndrome +[4] 
Inactive IndicationsDyslipidemiasDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A